Assessing the potential adverse consequences of supplemental calcium on cardiovascular outcomes: Should we change our approach to bone health?;Evaluación de consecuencias adversas potenciales de suplementos de calcio en resultados cardiovasculares: Se debe cambiar el manejo de la salud de los huesos?

Annals of Pharmacotherapy

Volumn 46, Issue 5, 2012, Pages 696-702

  Rojas Fernandez, Carlos H ^a,b   MacLaughlin, Eric J ^c   Dore, Naomi L ^d   Ebsary, Sally ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Calcium; Calcium supplements; Cardiovascular disease

Indexed keywords

CALCIUM; CALCIUM CARBONATE; CITRATE CALCIUM; VITAMIN D;

ARTICLE; BONE DENSITY; CARDIOVASCULAR RISK; EVIDENCE BASED MEDICINE; FRACTURE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; RISK REDUCTION; SIDE EFFECT; STROKE; VITAMIN SUPPLEMENTATION;

CALCIUM, DIETARY; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK;

EID: 84860996126     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q627     Document Type: Article

References (51)

1. National Osteoporosis Foundation. Fast facts. http://www.nof.org/node/40 (accessed 2011 Nov 17).
2. Nutrition and overweight. Healthy people 2010. 2nd ed. Washington, DC: US Department of Health and Human Services, 2000.
3. Department of Health and Human Services. Healthy people 2020. http:// www.healthypeople.gov/HP2020 (accessed 2011 Nov 17).
4. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. 2010. http://www.nof.org/professionals/clinical-guidelines (accessed 2011 Nov 17).
5. Papaioannou A, Morin S, Cheung AM, et al. 2010 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010;182:1864-1873.
6. Institute of Medicine of the National Academies. DRIs for calcium and vitamin D. http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D/DRI-Values.aspx (accessed 2011 Sept 24).
7. Bailey RL, Dodd KW, Goldman JA, et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 2010;140:817-822.
8. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta analysis. Lancet 2007;370:657-666.
9. Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supplementation: randomized controlled trial. BMJ 2008;336:262-266.
10. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta analysis. BMJ 2010;341:c3691.
11. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: re-analysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 2011;342:d2040.
12. Reid IR, Bolland MJ, Grey A. Does calcium supplementation increase cardiovascular risk? Clin Endocrinol (Oxf) 2010;73:689-695.
13. Using nontraditional risk factors in coronary heart disease risk assessment: US Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:474-482.
14. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation 2007;115:402-426.
15. Mason MA, Shepler BM. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis. Pharmacotherapy 2010; 30:741-748.
16. Kaluza J, Orsini N, Levitan EB, Brzozowska A, Roszkowski W, Wolk A. Dietary calcium and magnesium intake and mortality: a prospective study of men. Am J Epidemiol 2010;171:801-807.
17. Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007;115:846-854.
18. LaCroix AZ, Kotchen J, Anderson G, et al. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Geron-tol A Biol Sci Med Sci 2009;64:559-567.
19. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010;152:315-323.
20. Brazier M, Grados F, Kamel S, et al. Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multi center, randomized, double-blind placebo-controlled study. Clin Ther 2005;27: 1885-1893.
21. Reid IR, Bolland MJ, Grey A. Effect of calcium supplements on hip fractures. Osteoporosis Int 2008;19:1119-1123.
22. Prince RL, Devine A, Dhaliwal SS, Dick IM. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 2006;166:869-875.
23. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999;340:101-107.
24. Reid IR, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med 2006;119:777-785.
25. Lewis JR, Calver J, Zhu K, Flicker L, Prince RL. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. J Bone Miner Res 2011; 26:35-41.
26. Nordin C, Daly RM, Horowitz J, Metcalfe AV. Calcium and heart attacks: making too much of a weak case. BMJ 2010;341:c4997.
27. Nordin BEC, Lewis JR, Daly RM, et al. The calcium scare-what would Austin Bradford Hill have thought? Osteoporos Int 2011;22:3073-3077.
28. Abrahamsen B, Sahota O. Do calcium plus vitamin D supplements increase cardiovascular risk? BMJ 2011;342:d2080.
29. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-511.
30. Dobnig H, Pilz S, Scharnagl H et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-1349.
31. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629-1637.
32. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvita-min (D)3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-238.
33. Maestro B, Campion J, Davila N, Calle C. Stimulation by 1,25-dihy-droxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 2000;47:383-391.
34. O'Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU. 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 1997;272:H1751-H1758.
35. Oh J, Weng S, Felton SK, et al. 1,25(OH)2 Vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009;120:687-698.
36. Consensus conference: optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake. JAMA 1994;272:1942-1948.
37. Consensus Conference: osteoporosis prevention, diagnosis, and therapy. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. JAMA 2001;285:785-795.
38. Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 2003;9:544-564.
39. Boonen S, Vanderschueren D, Haentjens P, Lips P. Calcium and vitamin D in the prevention and treatment of osteoporosis-a clinical update. J Intern Med 2006;259:539-552.
40. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637-1642.
41. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-676.
42. Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004;19:370-378.
43. Reid IR, Bolland MJ, Grey A. Effect of calcium supplementation on hip fractures. Osteoporos Int 2008;19:1119-1123.
44. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-683.
45. Porthouse J, Cockayne S, King C, et al. Randomized controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005;330:1003.
46. The RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005;365:1621-1628.
47. Prince R, Nordin B. Comment on Reid et al.: effect of calcium supplementation on hip fractures. Osteoporosis Int 2009;20:831-832.
48. Tang BM. Does calcium supplementation really cause more hip fractures? Osteoporos Int 2009;20:833-834; author reply 835-6.
49. Calcium and cardiovascular risk. Pharmacist's Letter/Prescriber's Letter 2010;26:260901.
50. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010;152:315-323.
51. Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999;149:151-161.